140 related articles for article (PubMed ID: 32828943)
1. Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway.
Chen X; Ren L; Liu X; Sun X; Dong C; Jiang Y; Qin Y; Qu H; Jiao J; Wang S; Bai Y; Yang B
Life Sci; 2020 Nov; 261():118306. PubMed ID: 32828943
[TBL] [Abstract][Full Text] [Related]
2. Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
Chang X; Lu K; Wang L; Lv M; Fu W
Biosci Trends; 2018 May; 12(2):149-156. PubMed ID: 29607874
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
Li B; Zheng Z; Wei Y; Wang M; Peng J; Kang T; Huang X; Xiao J; Li Y; Li Z
Cardiovasc Diabetol; 2011 Jul; 10():69. PubMed ID: 21798071
[TBL] [Abstract][Full Text] [Related]
4. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
5. Skimmin protects diabetic cardiomyopathy in streptozotocin-induced diabetic rats.
Liang RK; Zhao YY; Shi ML; Zhang G; Zhao YJ; Zhang BG; Liang RJ
Kaohsiung J Med Sci; 2021 Feb; 37(2):136-144. PubMed ID: 33128488
[TBL] [Abstract][Full Text] [Related]
6. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
[TBL] [Abstract][Full Text] [Related]
7. Melatonin attenuates aortic oxidative stress injury and apoptosis in STZ-diabetes rats by Notch1/Hes1 pathway.
Ren BC; Zhang W; Zhang W; Ma JX; Pei F; Li BY
J Steroid Biochem Mol Biol; 2021 Sep; 212():105948. PubMed ID: 34224859
[TBL] [Abstract][Full Text] [Related]
8. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression.
Wang L; Bi X; Han J
IUBMB Life; 2020 Sep; 72(9):1997-2009. PubMed ID: 32734614
[TBL] [Abstract][Full Text] [Related]
9. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
[TBL] [Abstract][Full Text] [Related]
10. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
[TBL] [Abstract][Full Text] [Related]
11. Effects of ranolazine on cardiac function in rats with heart failure.
Wang GT; Li H; Yu ZQ; He XN
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9625-9632. PubMed ID: 31773713
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy.
Gui C; Zhu L; Hu M; Lei L; Long Q
Cardiovasc Pathol; 2012; 21(5):414-20. PubMed ID: 22285193
[TBL] [Abstract][Full Text] [Related]
13. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway.
Sun S; Yang S; An N; Wang G; Xu Q; Liu J; Mao Y
J Ethnopharmacol; 2019 Jun; 238():111857. PubMed ID: 30959142
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of Notch1 signaling activation against high glucose-induced myocardial cell injury: Analysis of its mechanisms of action.
Zhang J; Li B; Zheng Z; Kang T; Zeng M; Liu Y; Xia B
Int J Mol Med; 2015 Sep; 36(3):897-903. PubMed ID: 26202569
[TBL] [Abstract][Full Text] [Related]
15. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
[TBL] [Abstract][Full Text] [Related]
16. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
[TBL] [Abstract][Full Text] [Related]
17. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine improves oxidative stress and mitochondrial function in the atrium of acetylcholine-CaCl2 induced atrial fibrillation rats.
Zou D; Geng N; Chen Y; Ren L; Liu X; Wan J; Guo S; Wang S
Life Sci; 2016 Jul; 156():7-14. PubMed ID: 27208652
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 Promotes Myocardial Angiogenesis in the Rat Model of Diabetic Cardiomyopathy.
Gui C; Zeng ZY; Chen Q; Luo YW; Li L; Chen LL
Cell Physiol Biochem; 2018; 46(6):2325-2334. PubMed ID: 29742506
[TBL] [Abstract][Full Text] [Related]
20. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
